Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava filters -- devices used to keep blood clots from ...

Please provide your email address to receive an email when new articles are posted on . Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates ...

The patient with both recent bleeding and thrombotic events poses a great challenge to clinicians. The rationale for an IVC filter is that it would potentially reduce the risk of morbid or fatal ...

Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin. Background: Venous thrombosis is a frequent ...

Deep vein thrombosis is a medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can ...

Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. Of 182 patients, 103 were men and 79 were women. Median age was 59 years (range, 15 to 88 ...

Thrombophilic patients undergoing elective neurosurgery who receive a temporary inferior vena cava (IVC) filter show dramatically fewer thrombotic or hemorrhagic complications compared with ...

Use of inferior vena cava (IVC) filters declined in the United States following a 2010 safety communication from the US Food and Drug Administration (FDA), although the rate of implantation remains ...